FDA grants EUA for Merck’s COVID-19 oral drug

Just one day after the FDA approved it’s first COVID-19 antiviral drug, it then, also under EUA, approves Merck’s mutagentic antiviral drug molnupiravir.

• Danish doctors are hesitant to prescribe this new drug.
• Molnupiravir is under evaluation by TGA, for provisional registration.